G/TBT/N/CAN/463
4 August 2015 
(15-4016)  Page: 1/2
Committee on Technical Barriers to Trade  Original: English/French
 
  NOTIFICATION 
The following notification is being circulated in accordance with Article 10.6 
 
1. Notifying Member: CANADA 
If applicable, name of local government involved (Article 3.2 and 7.2):  
2. Agency responsible: Department of Health 
Name and address (including telephon e and fax numbers, email and website 
addresses, if available) of agency or authority designated to handle comments 
regarding the notification shall be indicated if different from above : 
Canada's Notification Authority and Enquiry Point 
Foreign Affairs, Trade and Development Canada 
Technical Barriers and Regulations Division (TIB) 111 Sussex Drive Ottawa, ON K1A 0G2 
Canada 
Telephone: (343)203-4273 Fax: (613)943-0346 
Email: enquirypoint@international.gc.ca   
3. Notified under Article 2.9.2 [X], 2.10 .1 [ ], 5.6.2 [ ], 5.7.1 [ ], other: 
4. Products covered (HS or CCCN where applic able, otherwise national tariff heading. 
ICS numbers may be provided in addition, where applicable): Barbituric Acid, 
Naloxegol and its salts, Methylnaltrexone and its salts, the salts of Naloxone, Naltrexone and 
Nalmefene and Catha Edulis Forsk, its preparations, derivatives, alkaloids and salts including Cathine and Cathinone and its salts (ICS: 11.120) 
5. Title, number of pages and language(s) of the notified document: Notice to 
interested parties – Proposal regarding an order amending the schedules to the Controlled Drugs and Substances Act (CDSA) and regulations amending the regulations to the CDSA to 
facilitate legitimate access to certain substances (2 pages, available in English and French)  
6. Description of content: This notice provides interested stakeholders with the opportunity 
to provide comments on Health Canada's proposal for the exclusion of barbituric acid, 
naloxegol and its salts, methylnaltrexone and its salts, as well as the salts of nalmefene, naloxone and naltrexone from the schedules to the CDSA and its regulations. This proposal 
also includes amendments to Part J of the Food and Drug Regulations (FDR) in order to 
add Catha edulis Forsk, cathine and cathinone in its schedule.  
The CDSA and its regulations provide a framework for the control of substances that can 
alter mental processes and that may cause harm to health or to society when diverted to 
an illicit market or use. It has come to th e attention of Health Canada that several 
substances that do not pose risks to public health and safety are captured under the schedules to the CDSA. In addition, certain substances scheduled under the Act are not 
listed under any of its regulations, thereby hampering access to these substances for 
legitimate purposes. Amendments to the sch edules to the CDSA and its regulations are 
therefore being proposed to address these issues. G/TBT/N/CAN/463 
 
- 2 - 
 
  7. Objective and rationale, including the nature of urgent problems where 
applicable: The purpose of these amendments are to exclude specific substances that do 
not pose a threat to public health or public safety from the schedules of the CDSA and its 
regulations and to facilitate legitimate access to specific substances that are currently 
controlled under the CDSA. 
8. Relevant documents: Canada Gazette , Part I, 23 May 2015, pages 1046-1047 (available 
in English and French) 
9. Proposed date of adoption: Anticipated for winter 2016 
Proposed date of entry into force: On the date the regulations are adopted  
10. Final date for comments: 8 October 2015 
11. Texts available from: Nati onal enquiry point [X] or address, telephone and fax 
numbers and email and website addresses, if available, of other body:  
The electronic version of the notice can be downloaded at: 
http://gazette.gc.ca/rp-pr/p1/20 15/2015-05-23/pdf/g1-14921.pdf 
http://gazette.gc.ca/rp-pr/p1/2015/201 5-05-23/html/notice-avis-eng.php#nb3  
http://gazette.gc.ca/rp-pr/p1/2015/201 5-05-23/html/notice-avis-fra.php#nb3